PatternsRadar
Sign in

SURAKSHASuraksha Diagnostic Limited

NSE
311.50INR-18.40 (-5.58%)Close · 20 Nov 2026
10 Nov 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹1,622 CrMarket cap
38.8P/E (TTM)
47.7%Delivery

Filings & corporate actions

10 results filed
CSV
Next results · Q3 FY27
Expected 5 Feb 2027 – 27 Feb 2027
Estimate: filed 36–58 days after quarter end, last 8 times
Dividend
₹0.50 per share · last 15 Sept 2026
2026
  • 10 NovresultsResults · Q2 FY27 · consolidated and standalone+1.7%NSE
  • 9 OctshareholdingShareholding · 30 Sept 2026+2.2%NSE
  • 15 SeptdividendDividend · ₹0.50 per share-0.2%
  • 13 AugresultsResults · Q1 FY27 · consolidated+12.6%NSE
  • 12 AugresultsResults · Q1 FY27 · standalone+12.6%NSE
  • 22 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
  • 21 MayresultsResults · Q4 FY26 · consolidated and standalone-2.2%NSE
  • 4 AprshareholdingShareholding · 31 Mar 2026+2.2%NSE
  • 13 FebresultsResults · Q3 FY26 · standalone0.0%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated+0.8%NSE
  • 17 JanshareholdingShareholding · 31 Dec 2025-2.1%NSE

Reaction to results · all yearsrose on day 0 in 3 of 9 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2710 Nov 2026+1.7%-0.7%—44.6×
Q1 FY2712 Aug 2026+12.6%+12.9%+21.3%32.9×
Q4 FY2621 May 2026-2.2%-12.0%-12.9%3.3×
Q3 FY265 Feb 2026+0.8%-0.3%-8.9%1.0×
Q2 FY2610 Nov 2025-2.8%-6.4%-13.8%1.5×
Q1 FY268 Aug 2025-0.5%+6.9%+2.9%2.7×
Q4 FY2528 May 2025-2.9%-1.3%-0.8%1.1×
Q3 FY258 Feb 2025-4.6%-17.3%-24.4%1.0×
Q2 FY2521 Dec 2024-1.9%-8.9%-18.4%—
Average+0.0%-3.0%-6.9%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+25.8%
Profit YoY+67.0%
Interest cost YoY+64.1%
Revenue QoQ+13.0%
Profit QoQ+15.4%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open325.50
Day range308.95 – 329.95
52-week range224.10 – 384.00
From 52w high-18.9%
RSI (14)40.5
ATR (14)17.50
Volume2.21L
Avg volume (20D)1.68L
Rel volume1.32×
Volatility (1Y)36.3%
Turnover₹7.0Cr
Traded value (NSE)₹7.0Cr
VWAP314.61
SMA 50 / 200328.94 / 291.55
Price band20%

Delivery percentage

Latest · 20 Nov 202647.7%
20-day avg50.8%
1-year avg58.0%
Percentile (own history)26th
Range13.2–92.6%
Sessions486

Over the last 20 sessions SURAKSHA settled 50.8% of its traded quantity, which is above average for an NSE equity. Its one-year average is 58.0%, so recent sessions are running 7.2 points lower than usual. The latest session ranks higher than 26% of the 486 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.16%
Dividend, trailing 12M₹0.50
Paid every year for1 yr
Shareholders60.8K · -6.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy714 days ago
IndustryHealthcare Service Provider

Performance returns

1D1W1M3M6M1Y
Price-5.58%-8.84%+7.80%+2.08%-2.69%+0.45%

Valuation

Market cap₹1,622 Cr
Market cap (NSE)₹1,622 Cr
Free-float cap₹826 Cr
P/E (TTM)38.8
P/E (NSE)41.7
EPS (TTM)8.03
P/B5.9
Net margin (TTM)12.1%
Other income / PBT7.2%
ROE16.5%
Debt / equity0.02
Shares outstanding5.21Cr
Listed6 Dec 2024

Ownership

Promoter49.10%
Promoter Δ QoQ0.00 pp
Public50.90%
FII13.97%
DII21.56%
Pledged0.10%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)77.781.487.699.1
YoY chg+30.5%+25.1%+20.7%+25.8%
Net profit (₹ Cr)7.26.212.815.0
YoY chg+21.0%-14.1%+40.0%+69.4%
Net margin9.3%7.6%14.7%15.1%
EPS1.441.212.502.88

Shareholding over time

By quarter

30 Sept 2026 · promoter 49.10% · public 50.90%
5 Dec 2024: promoter 48.78%31 Dec 2024: promoter 48.78%31 Mar 2025: promoter 48.78%30 Jun 2025: promoter 48.88%30 Sept 2025: promoter 48.98%31 Dec 2025: promoter 49.00%31 Mar 2026: promoter 49.10%30 Jun 2026: promoter 49.10%30 Sept 2026: promoter 49.10%
2024-122026-09
  • Promoter
  • Public and others
Promoter
49.10%
Public
50.90%
Promoter change
0.00 pp
Filed
9 Oct 2026
FII
13.97%
DII
21.56%
Promoter pledged
0.10%

Who the public is

Mutual funds
20.16%

+0.11 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
1.10%

+0.51 pp QoQ

Retail ≤ ₹2L
10.07%

-0.15 pp QoQ

HNI > ₹2L
1.57%

-0.15 pp QoQ

NRI
0.24%

+0.04 pp QoQ

Bodies corporate
3.01%

+1.43 pp QoQ

Shareholders
60,792

-6.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
RITU MITTALPromoter · Individual15.93%
ORBIMED ASIA II MAURITIUS LIMITEDForeign12.88%
SATISH KUMAR VERMAPromoter · Individual10.84%
SARLA KEJRIWALPromoter · Individual9.23%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHAMutual fund7.48%
KOTAK SMALL CAP FUNDMutual fund6.99%
SOMNATH CHATTERJEEPromoter · Individual5.10%
Tinni Investments LimitedPromoter · Corporate4.62%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/CMutual fund3.79%
Dneema Overseas Private LimitedPromoter · Corporate3.21%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 15 Sept 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.50₹0.50
Ex-dateRecord dateDeclaredAdjusted
15 Sept 2026—₹0.50₹0.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
9 months ago
Disclosures on record
17
16 open-market of the newest 17
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
25 Feb 2026Aparajita ChatterjeePromoterBuy9.0K₹25.8L286.7343.5K → 52.5K0.10%+0.02 pp7(2)told 25 Feb 2026
24 Feb 2026Aparajita ChatterjeePromoterBuy6.2K₹17.6L281.6337.3K → 43.5K0.08%+0.01 pp7(2)told 24 Feb 2026
24 Feb 2026Aparajita ChatterjeePromoterBuy15.8K₹45.0L284.7621.5K → 37.3K0.07%+0.03 pp7(2)told 24 Feb 2026
20 Feb 2026Aparajita ChatterjeePromoterBuy11.0K₹31.0L280.8610.4K → 21.5K0.04%+0.02 pp7(2)told 20 Feb 2026
10 Dec 2025Bipul Mittal HUFPromoterBuy1.4K₹4.0L274.7015.3K → 16.7K0.03%+0.00 pp7(2)told 9 Dec 2025
10 Dec 2025Bipul MittalPromoterBuy5.8K₹15.9L274.3215.3K → 21.1K0.04%+0.01 pp7(2)told 9 Dec 2025
29 Sept 2025Ritu MittalPromoterBuy19.1K₹57.7L301.6982.76L → 82.95L15.93%+0.04 pp7(2)told 29 Sept 2025
18 Aug 2025Dr. Somnath ChatterjeePromoterBuy7.8K₹24.7L317.2826.47L → 26.55L5.10%+0.01 pp7(2)told 18 Aug 2025
14 Aug 2025Dr. Somnath ChatterjeePromoterBuy8.2K₹24.8L302.4126.39L → 26.47L5.08%+0.02 pp7(2)told 14 Aug 2025
13 Aug 2025Dr. Somnath ChatterjeePromoterBuy8.2K₹24.8L300.9126.31L → 26.39L5.07%+0.02 pp7(2)told 13 Aug 2025
13 Aug 2025Dr. Somnath ChatterjeePromoterBuy8.2K₹24.8L302.5326.22L → 26.31L5.05%+0.02 pp7(2)told 12 Aug 2025
25 Jun 2025Dr. Somnath ChatterjeePromoterBuy7.5K₹24.7L331.9026.15L → 26.22L5.03%+0.01 pp7(2)told 24 Jun 2025
20 Jun 2025Bipul Mittal HUFPromoterBuy15.3K₹49.7L325.68— → 15.3K0.03%7(2)told 19 Jun 2025
20 Jun 2025Bipul MittalPromoterBuy15.3K₹49.8L326.14— → 15.3K0.03%7(2)told 19 Jun 2025
18 Jun 2025Dr. Somnath ChatterjeePromoterBuy7.6K₹24.9L326.5126.07L → 26.15L5.02%+0.01 pp7(2)told 18 Jun 2025
13 Jun 2025Dr. Somnath ChatterjeePromoterBuy7.6K₹24.9L327.4126.00L → 26.07L5.01%+0.01 pp7(2)told 13 Jun 2025

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 6 Dec 2024

CSV
2 of 2 deals
By year
DateDealClientQuantityPriceValue
6 Dec 2024Sell · bulkAAKRAYA RESEARCH LLP3.77L435.05₹16.4Cr
6 Dec 2024Buy · bulkAAKRAYA RESEARCH LLP3.77L434.91₹16.4Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SURAKSHA.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26RQ4 FY26AQ1 FY27Q2 FY27
Revenue from operations66.859.565.172.678.777.781.487.699.1
Other income1.30.60.80.90.90.60.81.11.5
Total income68.160.165.973.579.678.382.288.7100.6
Total expenses54.452.156.761.067.568.272.272.281.7
└ Finance costs2.12.02.12.72.83.23.93.74.8
└ Depreciation8.78.88.79.510.110.611.311.312.6
Profit before tax13.68.09.212.512.010.110.016.518.9
Tax expense3.52.12.03.33.22.83.83.73.9
Net profit10.26.07.29.28.87.26.212.815.0
EPS1.941.181.421.801.731.441.212.502.88
Net margin15.21%10.06%11.02%12.64%11.21%9.32%7.57%14.66%15.09%
PBT margin20.42%13.52%14.15%17.18%15.30%12.95%12.26%18.86%19.05%
Tax rate25.51%25.63%22.16%26.41%26.72%28.03%38.29%22.27%20.78%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 10 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY25FY25H1 FY26FY26H1 FY27
Total assets319.6333.5380.2448.1520.7
Current assets86.647.273.462.658.4
└ Cash & equivalents2.02.22.13.25.7
└ Other bank balances54.617.941.523.111.5
└ Current investments0.00.00.00.00.0
└ Trade receivables9.013.813.622.825.3
└ Inventories6.98.08.48.19.9
Total equity196.8210.2229.4243.5275.0
└ Attributable to owners197.4211.2230.4244.8276.2
└ Non-controlling interest(0.6)(1.0)(1.0)(1.4)(1.2)
└ Share capital8.610.410.410.410.4
Borrowings6.85.82.71.76.5
└ Current3.02.91.91.62.0
└ Non-current3.92.90.80.24.5
Trade payables13.713.616.420.923.3
Current liabilities45.342.741.859.684.6
Total liabilities122.8123.3150.8204.6245.7
Net debt(49.8)(14.3)(40.9)(24.6)(10.7)
Debt / equity0.030.030.010.010.02
Current ratio1.911.101.761.050.69

Cash flow, year to date

 H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow37.363.436.781.858.8
└ Capex(19.9)(42.0)(23.5)(67.3)(33.6)
Free cash flow17.421.313.214.525.2
Investing cash flow(25.2)(39.6)(21.8)(52.2)(47.6)
Financing cash flow(12.6)(24.0)(15.0)(28.7)(8.8)
└ Dividends paid0.00.00.00.00.0
└ Buybacks0.00.00.00.00.0
Net change in cash(0.5)(0.3)(0.1)1.02.5

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SURAKSHA at a glance

  • SURAKSHA closed at ₹311.5 on 20 Nov 2026, -5.58% on the day, +0.5% over one year, 18.9% below its 52-week high of ₹384.
  • Delivery was 47.7% of traded quantity on 20 Nov 2026, the 26th percentile of its own 486 sessions with a reading (20-session average 50.8%, 1-year average 58.0%).
  • Market capitalisation is ₹1,622 crore at a trailing P/E of 38.8 (trailing EPS ₹8.03).
  • Q2 FY27 results (consolidated, filed 10 Nov 2026): revenue ₹99 crore (+25.8% year on year), net profit ₹15 crore (+69.4%); the price moved +1.7% on the first session after.
  • Promoters held 49.10% at 30 Sept 2026, unchanged on the previous filing, with 0.10% of promoter shares pledged.
  • Q3 FY27 results are expected between 5 Feb 2027 and 27 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryHealthcare Service Provider
ISININE877V01027
SeriesEQ
Listed6 Dec 2024
IPO price441.00 · band Rs.420 to Rs.441
IPO listing6 Dec 2024
NSE market cap · 17 Nov 2026₹1,841 Cr
Free-float market cap (NSE)₹700 Cr
Shares outstanding (NSE)5.21Cr
History from6 Dec 2024
Sessions486

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.